- Home
- ANNX vs KTF Comparison
ANNX vs KTF Comparison
Compare ANNX & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- KTF
- Stock Information
- Founded
- ANNX 2011
- KTF 1988
- Country
- ANNX United States
- KTF United States
- Employees
- ANNX N/A
- KTF N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- KTF Finance Companies
- Sector
- ANNX Health Care
- KTF Finance
- Exchange
- ANNX Nasdaq
- KTF Nasdaq
- Market Cap
- ANNX 362.4M
- KTF 358.0M
- IPO Year
- ANNX 2020
- KTF N/A
- Fundamental
- Price
- ANNX $1.60
- KTF $9.18
- Analyst Decision
- ANNX Strong Buy
- KTF
- Analyst Count
- ANNX 5
- KTF 0
- Target Price
- ANNX $18.67
- KTF N/A
- AVG Volume (30 Days)
- ANNX 1.6M
- KTF 103.3K
- Earning Date
- ANNX 05-20-2025
- KTF 01-01-0001
- Dividend Yield
- ANNX N/A
- KTF 3.54%
- EPS Growth
- ANNX N/A
- KTF N/A
- EPS
- ANNX N/A
- KTF 0.39
- Revenue
- ANNX N/A
- KTF N/A
- Revenue This Year
- ANNX N/A
- KTF N/A
- Revenue Next Year
- ANNX N/A
- KTF N/A
- P/E Ratio
- ANNX N/A
- KTF $23.10
- Revenue Growth
- ANNX N/A
- KTF N/A
- 52 Week Low
- ANNX $1.29
- KTF $7.40
- 52 Week High
- ANNX $7.85
- KTF $9.12
- Technical
- Relative Strength Index (RSI)
- ANNX 38.84
- KTF 54.57
- Support Level
- ANNX $1.62
- KTF $9.10
- Resistance Level
- ANNX $2.01
- KTF $9.21
- Average True Range (ATR)
- ANNX 0.13
- KTF 0.08
- MACD
- ANNX 0.01
- KTF 0.04
- Stochastic Oscillator
- ANNX 0.00
- KTF 92.44
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.